ELTX
Elicio Therapeutics Inc.
NASDAQ: ELTX · HEALTHCARE · BIOTECHNOLOGY
$10.62
+2.91% today
Updated 2026-04-30
Market cap
$215.05M
P/E ratio
—
P/S ratio
—
EPS (TTM)
$-2.58
Dividend yield
—
52W range
$5 – $15
Volume
0.1M
Elicio Therapeutics Inc. (ELTX) Earnings
Quarterly earnings history, analyst estimates, and stock price reaction.
EPS beat streak
3 of 8
Last 8 quarters
Avg EPS surprise
-4.0%
Last 4 quarters
Revenue YoY growth
—
Most recent quarter
EPS YoY growth
+52.0%
Most recent quarter
Earnings surprise history (last 12 quarters)
Beat estimate Missed estimate
Quarterly EPS and revenue trend
Quarterly revenue EPS (diluted)
How the stock reacts to earnings
Avg 1-day reaction
-0.6%
Last 2 reports
Positive reaction rate
50%
1 of 2 quarters
Largest single-day move
-3.0%
2025-11-13
| Report date | EPS actual | Surprise | Close before | Close after | 1-day reaction |
|---|---|---|---|---|---|
| 2025-12-31 | $-0.49 | -10.1% | $7.91 | $8.05 | +1.8% |
| 2025-11-13 | $-0.60 | +11.8% | $9.19 | $8.91 | -3.0% |
Quarterly earnings history
| Fiscal quarter ending | EPS estimate | EPS actual | Surprise | Revenue | YoY revenue |
|---|---|---|---|---|---|
| 2025-12-31 | $-0.45 | $-0.49 | -10.1% | — | — |
| 2025-09-30 | $-0.68 | $-0.60 | +11.8% | — | — |
| 2025-06-30 | $-0.67 | $-0.66 | +1.5% | — | — |
| 2025-03-31 | $-0.73 | $-0.87 | -19.2% | — | — |
| 2024-12-31 | $-0.88 | $-1.02 | -16.6% | $1.17M | — |
| 2024-09-30 | $-0.73 | $-1.39 | -90.4% | — | — |
| 2024-06-30 | $-0.96 | $-0.64 | +33.3% | — | — |
| 2024-03-31 | $-1.09 | $-1.15 | -5.5% | — | — |
| 2023-12-31 | $-0.78 | $-1.75 | -124.4% | — | — |
| 2023-09-30 | $-0.80 | $-1.27 | -58.7% | — | — |
| 2023-06-30 | — | $-2.44 | — | — | — |
| 2023-03-31 | — | $-1.51 | — | — | — |
Frequently asked questions
Has Elicio Therapeutics Inc. beaten earnings estimates?
Elicio Therapeutics Inc. has beaten Wall Street EPS estimates in 3 of its last 8 quarterly reports, with an average EPS surprise of -4.0% over the last 4 quarters.
How does ELTX stock react to earnings?
ELTX stock has moved an average of -0.6% in the trading day following earnings over its last 2 reports, with positive reactions in 50% of those quarters.